Aqueous conversion kinetics and mechanisms of ancitabine, a prodrug of the antileukemic agent cytarabine.
The kinetics of conversion of the prodrug ancitabine to the anticancer drug cytarabine have been studied in aqueous solutions in the pH range of 1.5-10.7, temperature range of 19.5-80.0 degrees C, ionic strength range of 10(-4) to 1.5, and in the presence of several general-base catalysts. Under all conditions ancitabine was quantitatively converted to cytarabine. The pH-rate profiles were linear with slope = 1 in alkaline pH, becoming pH independent in the region of maximum stability at pH less than or equal to 4, where buffer catalysis was found to be insignificant and kobs approximately equal to (1.12 X 10(11) h-1)-exp [-10121 deg/T]. At 30 degrees C, pH less than or equal to 4, it is calculated that an aqueous ancitabine solution will maintain 90% of its initial concentration for 12 d. A novel method for measuring general-base catalysis in competition with predominating specific-base catalysis and in the presence of secondary salt effects at constant ionic strength was developed. Three mechanisms of hydrolytic prodrug conversion are proposed: nucleophilic hydroxide addition, general base-assisted nucleophilic water attack, and spontaneous water attack.
D003504:Ancitabine / Q000378:metabolism*; D001272:Atmosphere; D002384:Catalysis; D002626:Chemistry, Pharmaceutical; D003561:Cytarabine / Q000031:analogs & derivatives* / Q000032:analysis* / Q000378:metabolism; D004355:Drug Stability; D006851:Hydrochloric Acid; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D012972:Sodium Hydroxide; D013056:Spectrophotometry, Ultraviolet; D013696:Temperature
D003561:Cytarabine; D012972:Sodium Hydroxide; D003504:Ancitabine; D006851:Hydrochloric Acid